[193 Pages Report] A recent clinical study radiation level research with robotic catheterization and normal cardiac intervention procedures reveals that robotic catheterization systems show reduction of ionizing radiation exposure by 95%.This factor will be prominent in pushing the preference for robotic catheteriza.
Japan s in Atrial Fibrillation Device Market is opportunities and is expected to exhibit healthy growth of 12 2% CAGR from 2022 to 2032 fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.
Opaleye Management Inc. lessened its stake in Stereotaxis, Inc. (NYSEAMERICAN:STXS – Get Rating) by 23.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,185,000 shares of the company’s stock after selling 371,800 shares during the quarter. Opaleye Management Inc. owned about 1.58% […]
Opaleye Management Inc. lowered its stake in Stereotaxis, Inc. (NYSEAMERICAN:STXS – Get Rating) by 23.9% during the fourth quarter, HoldingsChannel reports. The firm owned 1,185,000 shares of the company’s stock after selling 371,800 shares during the quarter. Opaleye Management Inc.’s holdings in Stereotaxis were worth $2,453,000 as of its most recent filing with the Securities […]
ST. LOUIS, May 25, 2023 Stereotaxis , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO,. | May 25, 2023